Lymphogranuloma venereum (LGV)
Lymphogranuloma venereum (LGV) is a sexually transmitted infection (STI) caused by certain types of the bacterium Chlamydia trachomatis. It primarily affects the lymphatic system and is more common in regions like sub-Saharan Africa, Asia, and parts of Europe, but it can occur anywhere.
Key points about LGV:
Symptoms:
- Early stage: A small, painless ulcer or sore typically appears at the site of infection (e.g., genitals, anus, or mouth).
- Later stages: Swelling and pain in the lymph nodes, which can become enlarged and tender, often leading to complications like abscesses or fistulas if untreated.
- Rectal infections are common, particularly among men who have sex with men, causing symptoms like rectal pain, discharge, and bleeding.
Transmission: The infection is spread through direct contact with the mucous membranes during sexual activity, including vaginal, anal, and oral sex.
Diagnosis: It is diagnosed through laboratory tests, such as PCR testing, which can detect Chlamydia trachomatis DNA in samples taken from infected areas (genitals, anus, etc.).
Treatment: LGV is treated with antibiotics, usually doxycycline for 21 days. Early detection and treatment are crucial to prevent complications, including chronic pain or scarring.
Prevention: Safer sexual practices, such as using condoms, can reduce the risk of transmission.
LGV and the rise of infections:
In recent years, there has been an increase in LGV cases, particularly in developed countries, as the infection has become more common among certain high-risk populations, including men who have sex with men. Early detection and access to healthcare are vital to prevent complications.




.jpg)
Comments
Post a Comment